Considerations for Clinical Trials Targeting the Myocardial Interstitium

Area of Science:

• Cardiovascular Research
• Fibrosis Research
• Clinical Trial Design

Background:

• The myocardial interstitium is increasingly recognized as a key factor in cardiovascular disease.
• It plays a role in risk stratification and guiding therapeutic interventions.
• Current understanding necessitates focused clinical trials to validate its therapeutic significance.

Purpose of the Study:

• To review critical aspects of clinical trials targeting the myocardial interstitium.
• To discuss challenges and strategies for designing and conducting effective trials in this area.
• To provide insights using examples from ongoing clinical trials.

Main Methods:

• Review of existing literature and ongoing clinical trials.
• Discussion of key trial design elements: antifibrotic therapies, outcome measures (efficacy and mechanistic), sample size, duration, multicenter considerations.
• Exploration of recruitment strategies, including interstitial stratification and enrichment.

Main Results:

• The review synthesizes current knowledge on trial design for myocardial interstitial research.
• Identifies specific challenges in measuring efficacy and mechanistic outcomes.
• Highlights the importance of tailored recruitment and trial management strategies.

Conclusions:

• Clinical trials are crucial for establishing the myocardial interstitium as a therapeutic target.
• Careful consideration of trial design, outcome measures, and recruitment is necessary for success.
• Further research and well-designed trials will advance cardiovascular medicine by targeting myocardial interstitial fibrosis.